Zhong Lun advised Lepu Bio on the deal while Sidley represented Keymed Biosciences. Lepu Biopharma Co., Ltd and Keymed Biosciences Inc. signed a global exclusive license agreement...
Lepu Biopharma and Keymed Biosciences’ Licensing Agreement with AstraZeneca AB
Denali’s US$236 Million Business Combination With Longevity Biomedical
Sidley advised Denali Capital Acquisition Corp., while Nelson Mullins Riley & Scarborough LLP assisted Longevity Biomedical. US Tiger Securities acted as business combination advisor to Denali. Denali...